FDA recall, , Moderate risk
CLEAR EYES Maximum Itchy Eye Relief
CLEAR EYES Maximum Itchy Eye Relief lacks assurance of sterility and may be contaminated.
Summary by Recall Canary from the FDA notice
What happened
Prestige Brands Holdings, based in Tarrytown, New York, recalled CLEAR EYES Maximum Itchy Eye Relief, 0.5 fl oz (15 mL) per dropper bottle, Sterile, Dist. by Medtech Products Inc., a Prestige Consumer Healthcare Company, due to potential contamination and lack of assurance of sterility. The company began the recall on July 29, 2026, and the FDA added it to the Enforcement Report on August 13, 2026.
The recalled product was distributed nationwide in the USA. The recall was classified by the FDA on August 14, 2026, and included in the FDA's weekly enforcement report on August 19, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the NDC or UPC and lot code listed under your product.
A UPC is the number printed under a barcode. An NDC (National Drug Code) is usually printed on the drug's label.
Clear Eyes Maximum Itchy Eye Relief
- NDC
- 67172-999-01
- UPC
- 6 78112 65920 3
- Lot code
- 2552A
Recall details
- Company began the recall
- Sold in
Nationwide in the USA.
- Company
- Prestige Brands HoldingsTarrytown, New York
- Hazard
- Sterility problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99532
- Recall number
- D-0766-2026
- Quantity recalled
- 39,060 15mL-bottles
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
Classified by FDA · Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
